Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00483171 · ClinicalTrials.gov registry record · Phase 3
A 14-Month Study On The Effects Of CP-945,598 For The Prevention Of Weight Regain In Obese Patients
A Phase 3 study, sponsored by Pfizer.
- Terminated
- Registry status
- Phase 3
- Development phase
- 699
- Enrollment target
NCT00483171: Clinical Trial Phase 3 study, sponsored by Pfizer.
NCT00483171 is a Phase 3 study that was terminated before completion, run by Pfizer. The registered enrollment target is 699 participants, roughly in line with the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00483171, a Phase 3 study, was terminated before completion, sponsored by Pfizer.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 699 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if CP-945,598 is effective in the prevention of weight regain in obese subjects.
Interventions
- BEHAVIORAL Low Calorie Diet
- DRUG CP-945,598
- BEHAVIORAL Non-pharmacological weight loss program (NPP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 699 participants |
| Start Date | 2008-01 |
| Est. Completion | 2009-01 |
| Phase | Phase 3 |
Why NCT00483171 stopped before completion
NCT00483171 is an interventional study that assigns participants to a tested intervention. The registered 699 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target.
The record links to 0 conditions, and to 3 interventions - of which Low Calorie Diet is the first listed.
NCT00483171 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00483171 about?
NCT00483171 is a clinical study titled "A 14-Month Study On The Effects Of CP-945,598 For The Prevention Of Weight Regain In Obese Patients". The purpose of this study is to determine if CP-945,598 is effective in the prevention of weight regain in obese subjects.
What is the current status of trial NCT00483171?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 699 participants. The study started on 2008-01. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00483171?
The interventions under investigation include: Low Calorie Diet (BEHAVIORAL), CP-945,598 (DRUG), Non-pharmacological weight loss program (NPP) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00483171?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00483171's enrollment target sits among peer trials
699 516th of 2000 higher than 1,485 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07187115 · 699 participants · NA
A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wall Ablation for Persistent Atrial Fibrillation
- NCT00900419 · 700 participants
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
- NCT01804686 · 700 participants · Phase 3
A Long-term Extension Study of PCI-32765 (Ibrutinib)
- NCT02107989 · 700 participants
Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia